Pharma Reviews: No impact on CRISIL rating of pharma entities despite US FDA scrutiny

Says Akshay Chitgopekar, director, CRISIL Ratings: “India's pharmaceutical industry has to strengthen its systems and controls to address regulatory ...
Read more: No impact on CRISIL rating of pharma entities despite US FDA scrutiny